|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Highlights in pathogenesis of vitiligo显示文摘Vitiligo is a common pigmentary disorder. Many studies across decades and all over the world have attempted to illustrate the pathogenesis behind it; however, the pathogenesis of vitiligo remains elusive. This review article, we present the findings behind the most and updated theories behind this psychologically debilitating and disfiguring disease. The discussion begun with the role of genetic predisposition followed by neural theory first proposed in the 1950 s. Wehighlight the autoimmune hypothesis, followed by the reactive oxygen species model, zinc-α2-glycoprotein deficiency hypothesis, viral theory, intrinsic theory and biochemical, molecular and cellular alterations accounting for loss of functioning melanocytes in vitiligo. Many theories were elaborated to clarify vitiligo pathogenesis. It is a multifactorial disease involving the interplay of several factors. Future research is needed to clarify the interaction of these factors for better understanding of vitiligo pathogenesis and subsequent successful treatment. | Ghada F Mohammed Amal Hussein Gomaa Mohammed Saleh Al-Dhubaibi | 2015 | World Journal of Clinical Cases2015，3，3： | 13 |
| 2 | Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn’s disease显示文摘AIM: To investigate overlapping regions of the rpoB gene previously involved with rifamycin resistance in M. tuberculosis and seek correlation between rpoB mutations in clinical MAP strains with susceptibility to RIF and RFB. METHODS: We designed a molecular-based PCR method for the evaluation of rifabutin (RFB) and rifampicin (RIF) resistance based on probable determinant regions within the rpoB gene of MAP, including the 81 bp variable site located between nucleotides 1363 and 1443. The minimum inhibitory concentration (MIC) for RIF was also determined against 11 MAP isolates in attempt to seek correlation with rpoB sequences. RESULTS: We determined that MAP strain 18 had an MIC of > 30 mg/L and ≤ 5 mg/L for RIF and RFB respectively, and a significant and novel rpoB mutation C1367T, compared to an MIC of ≤ 1.0 mg/L for both drugs in the wild type MAP. The 30-fold increase in the MIC was a direct result of the rpoB mutation C1367T, which caused an amino acid change Thr456 to Ile456 in the drug’s binding site. In addition, MAP strain 185 contained five silent rpoB mutations and exhibited an MIC comparable to the wild-type. Moreover, our in vitroselected mutation in MAP strain UCF5 resulted in the generation of a new resistant strain (UCF5-RIF16r) that possessed T1442C rpoB mutation and an MIC > 30 mg/L and > 10 mg/L for RIF and RFB respectively. Sequencing of the entire rpoB gene in MAP strains UCF4, 18, and UCF5-RIF16r revealed an rpoB mutation A2284C further downstream of the 81 bp variable region in UCF4, accounting for observed slight increase in MIC. In addition, no other significant mutations were found in strains 18 and UCF-RIF16r. CONCLUSION: The data clearly illustrates that clinical and in vitro-selected MAP mutants with rpoB mutations result in resistance to RIF and RFB, and that a single amino acid change in the beta subunit may have a significant impact on RIF resistance. Unconventional drug susceptibility testing such as our molecular approach will be beneficial for evaluation of antibiotic effectiveness. This molecular approach may also serve as a model for other drugs used for treatment of MAP infections. | Daniel R Beckler Sammer Elwasila George Ghobrial John F Valentine Saleh A Naser | 2008 | World Journal of Gastroenterology2008，14，17： | 2 |
| 3 | Blood classical monocytes phenotype is not altered in primary non-small cell lung cancer显示文摘AIM: To evaluate the M1 and M2 monocyte phenotype in patients with non-small cell lung cancer(NSCLC) compared to controls. Also, to examine the expression of Th1 and Th2 cytokines in plasma of NSCLC vs controls. METHODS: Freshly prepared peripheral blood mononuclear cells samples were obtained from patients with NSCLC(lung adenocarcinoma and squamous cell lung carcinoma) and from non-cancer controls. Flow cytometry was performed to investigate M1 and M2 phenotypes in peripheral monocytes(classical monocytes CD14+, CD45+ and CD16-) using conventional surface markers. Th1 and Th2 cytokine production was alsoanalysed in the plasma using cytometric bead array technique. RESULTS: There were no significant difference in expression of M1(HLA-DR) and/or M2 markers(CD163 and CD36) markers on classical monocytes in patients with NSCLC compared to non-cancer controls. Expression of CD11 b, CD11 c, CD71 and CD44 was also shown to be similar in patients with NSCLC compared to noncancer controls. Th1 and Th2 cytokines [interleukin(IL)-1β, IL-2, IL-4, IL-5, IL-8, IL-10, IL-12(p70), tumor necrosis factor(TNF)-α, TNF-β, and interferon-γ] analysis revealed no significant difference between patients with NSCLC and non-cancer controls. CONCLUSION: This study shows no alteration in peripheral monocyte phenotype in circulating classical monocytes in patients with NSCLC compared to noncancer controls. No difference in Th1 and Th2 cytokine levels were noted in the plasma of these patients. | Saleh A Almatroodi Christine F Mc Donald Allison L Collins I an A Darby Dodie S Pouniotis | 2014 | World Journal of Clinical Oncology2014，5，5： | 2 |
| 4 | Effect of vitamin E and human placenta cysteine peptidase inhibitor on expression of cathepsins B and L in implanted hepatoma Morris 5123 tumor model in Wistar rats显示文摘AIM: To examine the effectiveness of human placental inhibitors, by injecting vitamin E to rats with transplanted Norris-5123 hepatoma, on the expression of cathepsins B and L in tumor, liver, lung and blood sera after transplantation of Norris 5123 hepatoma.METHODS: Animals were divided into 10 groups receiving three different concentrations of vitamin E and inhibitors along or in combination and compared with negative control (healthy rats) and positive control (tumor rats). Effectiveness of treatment was evaluated with regard to survival time,tumor response and determination of the activities of proteolytic enzymes and their inhibitors using flurogenic substrates.RESULTS: Cathepsins B and L activities were elevated by 16-fold in comparison with negative control tissues, and their endogenous inhibitor activity decreased by 1.2-fold before treatment. In several cases, tumors completely disappeared following vitamin E plus human placental cyteine protease inhibitor (CPI) compared with controls.The number of complete tumor responses was higher when 20 m/kg vitamin E plus 400 μg of CPI was used, i.e.7/10 rats survived more than two mo. Cathepsins B and L were expressed significantly in tumor, liver, lung tissues and sera in parallel to the increasing of the endogenous inhibitor activity compared with the controls after treatment (P<0.0001).CONCLUSION: The data indicate formation of metastasis significantly reduced in treated rats, which might provide a therapeutic basis for anti-cancer therapy. | Tadeusz Sebzda Piotr Hanczyc Yousif Saleh Bernice F Akinpelumi Maciej Siewinski Jerzy Rudnicki | 2005 | World Journal of Gastroenterology2005，11，4： | 2 |
| 5 | Efficacy of Gold Nanoparticles against Nephrotoxicity Induced by Schistosoma mansoni Infection in Mice显示文摘Objective In this study, the ameliorative effects of gold nanoparticles(gold NP) on the renal tissue damage in Schistosoma mansoni(S. mansoni)-infected mice was investigated. Methods High-resolution transmission electron microscopy was used for the characterization of NP. The gold NP at concentrations of 250, 500, and 1000 μg/kg body weight were inoculated into S. mansoni-infected mice. Results The parasite caused alterations in the histological architecture. Furthermore, it induced a significant reduction in the renal glutathione levels; however, the levels of nitric oxide and malondialdehyde were significantly elevated. The parasite also managed to downregulate KIM-1, NGAL, MCP-1, and TGF-β mR NA expression in infected animals. Notably, gold NP treatment in mice reduced the extent of histological impairment and renal oxidative damage. Gold NP were able to regulate gene expression impaired by S. Mansoni infection. Conclusion The curative effect of gold NP against renal toxicity in S. mansoni-infected mice is associated with their role as free radical scavengers. | Mohamed A Dkhil Mona F Khalil2 Amira A Bauom Marwa SM Dia Saleh A1-Qura | 2016 | Biomedical and Environmental Sciences2016，29，11： | 2 |
| 6 | Phase Ⅱ study of arsenic trioxide in patients with relapsed or refractory multiple myeloma显示文摘 | Hussein M A Saleh M Ravandi F | 2004 | Br J Haematol2004，125，4： | 1 |
| 7 | Cell penetrating peptides: overview and applications to the delivery of oli- onucleotides显示文摘 | Said hassane F Saleh AF Abes R | 2010 | Cell Mol Life Sci2010，67，5： | 1 |
| 8 | High efficacy and low toxicityof short-course oral valganciclovir as pre-emptive therapy for hemato-poietic stem cell transplant cytomegalovirus infection显示文摘 | Saleh AJ Al Mohareb F Al Rabiah F | 2010 | HematolOncol Stem Cell Ther2010，3，3： | 1 |
| 9 | Reliability and validityof non-invasive imaging of internal carotid artery pseudo-occlusion显示文摘 | Fiirst G Saleh A Wenserski F | 1999 | Stroke1999，30，7： | 1 |
| 10 | Flavone C-glycosides from seeds of fenugreek, Trigonellafoenum-graecum L显示文摘 | Saleh R Torgils F Oyvind M A | 2010 | Journal of Agricultural and Food Chemistry2010，58，： | 1 |
| 11 | Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma显示文摘 | Hussein MA Saleh M Ravand F | 2004 | Br J Haematol2004，125，6： | 1 |
| 12 | Advances in Nod-like receptors (NLR) biology显示文摘 | Barbé F Douglas T Saleh M | 2014 | Cytokine Growth Factor Rev2014，25，6： | 1 |
| 13 | Flavonoids of Phlomis aurea 显示文摘 | Ei-Negoumy S I Abdalla M F Saleh N A M | 1986 | Phytochemstry1986，25，3： | 1 |
| 14 | The distally based sural artery flap for ankle and foot coverage显示文摘 | Cheema T A Saleh E S De Carvalho A F | 2007 | J Foot Ankle Surg2007，46，1： | 1 |
| 15 | Phase Ⅱ study of arsenic trioxide in patients with relapsed or refractory multiple myeloma显示文摘 | Hussein MA Saleh M Ravandi F | 2004 | Br J Haematol2004，125，4： | 1 |
| 16 | Phase 2 study of arsenic troxide in patients with relapsed or refractory multiple myeloma显示文摘 | HUSSEIN M A SALEH M RAVANDI F | 2004 | Haemata2004，125，： | 1 |
| 17 | Laparoscopic management of non-communicating rudimentary horn in a dysmenorrheic and infertile patient显示文摘 | Saleh A M Sultan S F Al-Jawad H M | 2003 | Saudi Med J2003，24，2： | 1 |
| 18 | Protein splicing in cis and in trans显示文摘 | SALEH L PERLER F B | | 0，，04： | 1 |
| 19 | Protein splicing in cis and in trans显示文摘 | Saleh L Perler F B | 2006 | Chem Rec2006，6，4： | 1 |
| 20 | Total knee arthroplasty after open reduction and internal fixation of fractures of the tibial plateau显示文摘 | Khaled J Saleh M Pamela F | 2001 | J Bone Joint Surg Am2001，83，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员